The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(3-Cyano-5-cyclopropyl-4-hydroxy-benzoyl)-1,1-dioxo-1,2-dihydro-3H-1,3-benzothiazole ID: ALA4740995
PubChem CID: 51349185
Max Phase: Preclinical
Molecular Formula: C18H14N2O4S
Molecular Weight: 354.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1cc(C(=O)N2CS(=O)(=O)c3ccccc32)cc(C2CC2)c1O
Standard InChI: InChI=1S/C18H14N2O4S/c19-9-13-7-12(8-14(17(13)21)11-5-6-11)18(22)20-10-25(23,24)16-4-2-1-3-15(16)20/h1-4,7-8,11,21H,5-6,10H2
Standard InChI Key: HJNASESSRLKUIE-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
41.4869 -16.9175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.4910 -17.7347 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
42.1967 -17.3225 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.2981 -17.9988 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2969 -18.8183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0050 -19.2273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0032 -17.5899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7118 -17.9952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7166 -18.8184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.5010 -19.0682 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.9810 -18.3994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7580 -19.8439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2148 -20.4544 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.5583 -20.0091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8106 -20.7872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6101 -20.9526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1543 -20.3418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8934 -19.5629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.0946 -19.4012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9548 -20.5060 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.8688 -21.7248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.1254 -22.5006 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.4329 -18.9483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.2077 -18.6885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.5953 -18.1474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 2 1 0
2 8 1 0
10 12 1 0
12 13 2 0
12 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
21 22 3 0
16 21 1 0
24 23 1 0
25 24 1 0
23 25 1 0
18 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 354.39Molecular Weight (Monoisotopic): 354.0674AlogP: 2.53#Rotatable Bonds: 2Polar Surface Area: 98.47Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 7.69CX Basic pKa: ┄CX LogP: 2.04CX LogD: 1.86Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.89Np Likeness Score: -0.89
References 1. Uda J,Kobashi S,Miyata S,Ashizawa N,Matsumoto K,Iwanaga T. (2020) Discovery of Dotinurad (FYU-981), a New Phenol Derivative with Highly Potent Uric Acid Lowering Activity., 11 (10): [PMID:33062187 ] [10.1021/acsmedchemlett.0c00176 ]